Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Fund Type: ETF
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: U.S.

Market Vectors Pharmaceutical ETF

+ Add to Watchlist

VEFV:GR

35.6500 EUR 0.0800 0.22%

As of 10:44:57 ET on 05/17/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Market Vectors Pharmaceutical ETF (VEFV)

Open: 35.5100 High - Low: 35.6500 - 35.5100 Primary Exchange: Berlin
Volume: 0 52-Week Range: 21.2000 - 35.7300 Beta vs MVPPHTR: -

ETF Chart for VEFV

No chart data available.
  • VEFV:GR 35.6500
  • 1M
  • 1Y
35.7300
Interactive VEFV Chart

Previous Close

Fund Profile & Information for VEFV

Market Vectors Pharmaceutical ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the US Listed Pharmaceutical 25 Index.

Inception Date: 2009-03-20 Telephone: 1-212-293-2000
Managers: HAO-HUNG LIAO "PETER"
Web Site: www.vaneck.com

Fundamentals for VEFV

NAV -
Assets (M) (on 2013-04-30) 277.3334
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for VEFV

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2013-04-01) 0.3890
Dividend Yield (ttm) 3.40%

Performance for VEFV

1-Month +1.66% 1-Year -
3-Month +8.83% 3-Year -
Year To Date - 5-Year -
Expense Ratio 0.35

Top Fund Holdings for VEFV

Filing Date: 05/16/2013
Name Position Value % of Total
Johnson & Johnson 338,773 29,625,699 12.138%
Pfizer Inc 871,263 25,484,443 10.441%
Novartis AG 288,614 21,648,936 8.870%
Merck & Co Inc 366,290 16,984,867 6.959%
Sanofi 279,693 15,162,158 6.212%
GlaxoSmithKline PLC 282,447 14,718,313 6.030%
AbbVie Inc 268,670 12,415,241 5.087%
AstraZeneca PLC 221,680 11,489,674 4.707%
Bristol-Myers Squibb Co 268,529 11,484,985 4.705%
Abbott Laboratories 295,875 10,897,076 4.465%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil